GlaxoSmithKline posts Q2FY22 consolidated PAT at Rs. 204.24 Cr

GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021

EMA encourages companies to submit type I variations by end- November

Marketing authorisation holders are advised to submit any type IB variations or groupings of type IBs and type IAs by 3rd December 2021 for a start of procedure in 2021

Transforming Healthcare Through AI

Yashoda Hospitals opens world-class Biplane Neuro Cath lab for brain stroke

It launched the most advanced "DTAS" (Direct to Angio Suite) & State of the art ‘Neuro-Angio’ technology

Indian Pharma Market witnesses rise in volumes and prices in September.

Acute therapies continue to report strong growth compared to chronic ones.

Rainbow hospital gives new lease of life to infant on ECMO support

The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease

WHO selects Medigen’s Covid-19 vaccine for solidarity trial

Following the review of around 20 candidate vaccines by the external advisory group, MVC's vaccine was selected as one of two to be included in the global trial

Dr Lal PathLabs to acquire Suburban Diagnostics for Rs 925 crore

Dr Lal PathLabs revenue contribution from west India to go up from 10% to 24% post-acquisition basis FY21

Apollo Hospitals announces free Covid-19 vaccines to kids with co-morbidities

The list of kids with co-morbidities eligible for vaccination would be announced by the government

Lupin enters Guinness Records highlights rise in strokes

This unique record was made possible by collating hard copies of the books in a structured manner